— Know what they know.
Not Investment Advice

VBLT NASDAQ

Vascular Biogenics Ltd.
1W: -34.2% 1M: -33.8% 3M: -44.2% 1Y: +13.0% 3Y: -87.6% 5Y: -89.2%
$0.16
Last traded 2023-10-16 — delisted
NASDAQ · Healthcare · Biotechnology · $12.1M mcap · 58M float · 0.066% daily turnover

📊 Key Metrics

TTM
$1M
Revenue
+3.8% YoY
$-13M
Net Income
+64.3% YoY
$-18M
Free Cash Flow
+47.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-47.0%
ROA-36.0%
ROIC1069.1%

Valuation

P/E-0.4
P/B0.5
EV/EBITDA-0.5

Leverage

Debt/Equity0.00
Current Ratio4.63
Interest Cov.459.9x

Quality Scores

Piotroski F4/9
Altman Z-9.03
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms